FIELD: medicine, pharmacy. SUBSTANCE: active component - budesonid or salbutamol where particles of size is 90% (not less) of component mass. Filling agent: sodium benzoate or lactose where particles of size 50-400 mcm - 90% of filling agent mass, not less. Preparation is used for treatment of different pulmonary diseases, in part, as antiasthmatic agent. EFFECT: enhanced effectiveness of preparation.
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR INHALATION | 2006 |
|
RU2338552C2 |
| POWDER INHALER | 2004 |
|
RU2258539C1 |
| POWDER INHALER | 2008 |
|
RU2376040C1 |
| INHALER FOR INTRODUCING POWDER-LIKE DRUGS | 1999 |
|
RU2163149C1 |
| FILLER FOR CAPSULAR INHALER | 2016 |
|
RU2634258C1 |
| INHALATION PREPARATION FOR TREATING BRONCHAIL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD FOR PREPARING IT | 2012 |
|
RU2504382C1 |
| PHARMACEUTICAL INHALED MEDICATION FOR TREATMENT OF BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE LUNG DISEASE, CONTAINING MICRONISED TIOTROPIUM BROMIDE AS ACTIVE SUBSTANCE AND METHOD OF ITS PRODUCTION | 2012 |
|
RU2522213C2 |
| INHALATION PREPARATION FOR TREATING BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD FOR PREPARING IT | 2012 |
|
RU2510267C2 |
| INHALATION PREPARATION FOR TREATING RESPIRATORY DISEASES CONTAINING MICRONISED SALMETEROL XINAFOATE AND MICRONISED FLUTICASONE PROPIONATE AS ACTIVE SUBSTANCES AND METHOD FOR PREPARING IT | 2012 |
|
RU2494730C1 |
| METHOD FOR PREPARING FINE PHARMACEUTICAL COMPOSITIONS OF SALBUTAMOL | 2012 |
|
RU2504370C1 |
